Dynamic Devices supports DIPG research with Lynx platform

🎗️ September is Childhood Cancer Awareness Month 🎗️ Diffuse intrinsic pontine glioma (DIPG), a form of diffuse midline glioma (DMG), is the most deadly childhood cancer and, tragically, has no cure. Most children survive only months after diagnosis. At Dynamic Devices, we are honored that Professor Matt Dun and the Cancer Signalling Research Group at the University of Newcastle use our Lynx liquid handling platform—affectionately known as “JEM-Bot”—to accelerate #DIPG research. Professor Dun’s work is deeply personal—after losing his four-year-old daughter, Josephine (“Josie”), to DIPG, he dedicated his career to finding better treatment strategies for children and families facing this devastating disease. As part of the research and testing process, the Dun Lab Team uses JEM-Bot to: 🔬 Achieve >400x more testing throughput – completing in a week what used to take two months, and screening multiple drug combinations in the growth pattern of DIPG cells. ✅ Eliminate human error – preventing 15-20% of tests from needing to be repeated. ⏱ Deliver faster, more detailed results – enabling double/triple drug combination testing and complex dosing schedules to better predict which treatments could help patients. But this progress depends on continued support. Donations to RUN DIPG directly fund new equipment, expand research capabilities, and help bring innovative clinical trials to children and families sooner. 🔗 Learn more and support the cause: https://rundipg.org/ 💛 Together, we can turn awareness into action—and bring hope to children fighting DIPG. #RUNDIPG #MovingTowardsACure #ChildhoodCancerAwarenessMonth #MedicalResearch #DunLab

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories